- Neuland Laboratories Ltd. plans to open a commercial-scale peptide manufacturing facility in summer 2026 at its Bonthapally campus in Hyderabad, India.
- The first manufacturing module will add 6,370 liters of peptide synthesis capacity, supported by about $30 million in customer commitments.
Neuland Laboratories Ltd. plans to open a commercial-scale peptide manufacturing facility in summer 2026 at its 17-acre Bonthapally campus in Hyderabad, India. The expansion aims to increase manufacturing capacity for complex peptides, including those used in GLP-1 therapies, amid rising global demand.
The first of four planned manufacturing modules is expected to become operational this summer. According to the company, the initial unit will add 6,370 liters of solid- and liquid-phase peptide synthesis capacity, supported by approximately $30 million in customer commitments. Equipment will include liquid-phase peptide synthesis (LPPS) reactors ranging from 250 to 3,000 liters and solid-phase peptide synthesis (SPPS) reactors with capacities up to 500 liters.
Construction of the facility began last year. The site is designed to support production volumes from early development through multi-ton commercial manufacturing. The company said the facility will allow incremental expansion, with space for additional 2,000-liter SPPS units and multiple 5,000-liter LPPS reactors in future modules.
“Building on the strength of our reputation among innovator and biotech customers for complex API capabilities, this new facility marks our strategic entry into commercial-scale peptide manufacturing.”
Saharsh Davuluri, Vice Chairman and Managing Director of Neuland Labs
The new facility will incorporate digital operations, distributed control system automation, and electronic batch record systems. It will also include scaled purification and drying capabilities, such as multi-column preparative HPLC, large lyophilizers, expanded solvent-handling infrastructure, and upgraded waste-management systems intended to improve batch consistency and production cycle times.
